Metabolic and Endocrine Status in Women With Prior Preterm Birth
NCT ID: NCT01355536
Last Updated: 2011-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
262 participants
OBSERVATIONAL
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
NCT02564250
Prognosis of Extremely Premature Birth
NCT01150396
Maternal and Fetal Metabolic Changes
NCT06288126
Pregnancy Cohort Study: Pregnancy as a Window to Future Health
NCT06925815
Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
NCT05872009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Preterm birth group
Women with prior preterm birth
No interventions assigned to this group
Term birth group
Women with prior term birth
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having Namsos Hospital as their local Hospital during pregnancy
Exclusion Criteria
* Lack of communication skills in Norwegian or English
* Ongoing pregnancy
* Ongoing breastfeeding
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian University of Science and Technology
OTHER
The Royal Norwegian Ministry of Health
OTHER
Namsos Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital of Namsos
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tina Eilertsen, MD
Role: PRINCIPAL_INVESTIGATOR
Namsos Hospital, Nord- Trøndelag Hospital Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Namsos Hospital, Nord- Trøndelag Hospital Trust
Namsos, Nord- Trøndelag, Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod. 2012 Aug;27(8):2494-502. doi: 10.1093/humrep/des213. Epub 2012 Jun 12.
Eilertsen TB, Vanky E, Carlsen SM. Increased prevalence of diabetes and polycystic ovary syndrome in women with a history of preterm birth: a case-control study. BJOG. 2012 Feb;119(3):266-75. doi: 10.1111/j.1471-0528.2011.03206.x. Epub 2011 Dec 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
46011600-57
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.